Immune-Mediated Inflammatory Diseases

Anti-COVID-19 antibody responses are attenuated in patients who receive infliximab for inflammatory bowel disease, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit.

Emerging data are showing solid efficacy and safety of COVID-19 vaccines in individuals with rheumatic and immune-mediated diseases, according to a presentation at the United Rheumatology Spring Virtual conference.

Experimental studies indicate that sleep loss can lead to elevated concentrations of proinflammatory cytokines and enhance the perception of pain among patients with immune-mediated inflammatory diseases, according to a speaker here.